{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T19:29:23Z","timestamp":1782674963415,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.euf.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T22:11:07Z","timestamp":1579903867000},"page":"366-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7548-1580","authenticated-orcid":false,"given":"Hiroshi","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9319-1373","authenticated-orcid":false,"given":"Yuma","family":"Waseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3632-2901","authenticated-orcid":false,"given":"Hajime","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-9294","authenticated-orcid":false,"given":"Toshiki","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minato","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Ishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2440-5104","authenticated-orcid":false,"given":"Yoh","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2020.01.006_bib0005","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euf.2020.01.006_bib0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/iju.13509","article-title":"Prediction models for progression of non-muscle-invasive bladder cancer: a review","volume":"25","author":"Fujii","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2020.01.006_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.01.006_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.01.006_bib0025","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.juro.2011.07.076","article-title":"A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group","volume":"186","author":"Brausi","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.01.006_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.juro.2014.02.2573","article-title":"Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer","volume":"192","author":"Kamat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.01.006_bib0035","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.urolonc.2016.05.028","article-title":"Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations","volume":"34","author":"Kassouf","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2020.01.006_bib0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000019636","article-title":"Significance of bladder neck involvement on progression in superficial bladder cancer","volume":"33","author":"Fujii","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.01.006_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2013.04.001","article-title":"Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study","volume":"32","author":"Kobayashi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2020.01.006_bib0050","doi-asserted-by":"crossref","unstructured":"Waseda Y, Kobayashi S, Kanda E, et al. Impact of bladder neck involvement on recurrence in patients with non-muscle invasive bladder cancer: an analysis based on a time-dependent model. Clin Genitourin Cancer. In press. https:\/\/doi.org\/10.1016\/j.clgc.2019.10.005.","DOI":"10.1016\/j.clgc.2019.10.005"},{"key":"10.1016\/j.euf.2020.01.006_bib0055","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/0959-8049(95)00287-S","article-title":"Factors affecting recurrence and progression in superficial bladder tumours","volume":"31A","author":"Kurth","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euf.2020.01.006_bib0060","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s12032-011-9999-4","article-title":"Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer","volume":"29","author":"Vukomanovic","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.euf.2020.01.006_bib0065","unstructured":"Mostofi F, Sobin L, Torloni H, editors. Histological typing of urinary bladder tumours. Geneva, Switzerland: World Health Organization; 1973."},{"key":"10.1016\/j.euf.2020.01.006_bib0070","doi-asserted-by":"crossref","unstructured":"Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. ed. 6. New York, NY: Wiley-Liss; 2002.","DOI":"10.1002\/0471463752"},{"key":"10.1016\/j.euf.2020.01.006_bib0075","series-title":"Atlas of exfoliative cytology","author":"Papanicolaou","year":"1954"},{"key":"10.1016\/j.euf.2020.01.006_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2013.07.007","article-title":"Significance of positive urine cytology on progression and cancer-specific mortality of non-muscle-invasive bladder cancer","volume":"12","author":"Koga","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2020.01.006_bib0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.euo.2018.08.018","article-title":"Tumor location may predict adverse pathology and survival following definitive treatment for bladder cancer: a national cohort study","volume":"2","author":"Weiner","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2020.01.006_bib0090","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1541-7786.MCR-12-0274","article-title":"Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma","volume":"10","author":"van der Horst","year":"2012","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.euf.2020.01.006_bib0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2184.2007.00424.x","article-title":"Urothelial progenitor cells: regional differences in the rat bladder","volume":"40","author":"Nguyen","year":"2007","journal-title":"Cell Prolif"},{"key":"10.1016\/j.euf.2020.01.006_bib0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urolonc.2016.11.014","article-title":"Characterizing intermediate-risk non-muscle-invasive bladder cancer: implications for the definition of intermediate risk and treatment strategy","volume":"35","author":"Matsumoto","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2020.01.006_bib0105","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-5347(05)66441-5","article-title":"Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance","volume":"165","author":"Donat","year":"2001","journal-title":"J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920300225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920300225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:51:44Z","timestamp":1762498304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456920300225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2405456920300225"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2020.01.006","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}